脑干海绵状血管瘤的临床治疗决策  

Discussion on clinical treatment decision of brainstem cavernous hemangioma

作　　者：林学磊 谢源阳[1] 李学军[1] LIN Xue-lei;XIE Yuan-yang;LI Xue-jun(Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, China)

机构地区：[1]中南大学湘雅医院神经外科,长沙410008

出　　处：《临床神经外科杂志》2020年第3期343-347,共5页Journal of Clinical Neurosurgery

摘　　要：脑干海绵状血管瘤(BSCM)位于脑干,毗邻锥体束、脑神经核团等重要脑功能结构,破裂出血可引起破坏性极大的临床事件。目前治疗方式分为手术切除、放射外科和保守治疗。神经外科医生需要对脑干海绵状血管瘤自然史充分了解,同时结合自己的丰富经验去加以权衡从而做出治疗决策。本文对脑干海绵状血管瘤的治疗及并发症的防治指导临床决策进行综述,同时指出目前研究存在的不足,并就如何进一步形成规范治疗进行展望。Brain stem cavernous hemangioma,adjacent to important brain functional structures such as pyramidal tracts and cerebral nucleus,if bleeding,is a highly destructive clinical event.Current treatment options include surgical resection,radiosurgery,and conservative treatment.Choosing the right treatment strategy requires a neurosurgeon to fully understand the natural history of brain stem cavernous hemangioma(BSCM)and to balance it with their own experiences.This article summarizes the treatment results of BSCM and the prevention and treatment of complications,and points out the shortcomings and prospects for standardized treatment guidelines.

关 键 词：脑干海绵状血管瘤 手术切除 伽玛刀放射治疗 保守治疗 

分 类 号：R739.41[医药卫生—肿瘤]